Skip to menu Skip to content Skip to footer
Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Overview

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Works

Search Professor Dan Siskind’s works on UQ eSpace

389 works between 2007 and 2025

1 - 20 of 389 works

2025

Journal Article

Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel

Siskind, Dan, Northwood, Korinne, Pillinger, Toby, Chan, Sherry, Correll, Christoph, Cotes, Robert O, Every-Palmer, Susanna, Hahn, Maggie, Howes, Oliver D, Kane, John M, Kelly, Deanna, Korman, Nicole, Lappin, Julia, Mena, Cristián, Myles, Nick, McCutcheon, Robert A, Siskind, Dan, McCutcheon, Robert A, Northwood, Korinne, Pillinger, Toby, Chan, Sherry, Correll, Christoph U, Cotes, Robert, Every-Palmer, Susanna, Hahn, Margaret, Howes, Oliver, Kane, John M, Kelly, Deanna L, Korman, Nicole ... Yung, Alison (2025). Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel. The Lancet Psychiatry. doi: 10.1016/s2215-0366(25)00098-7

Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel

2025

Journal Article

Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

Siskind, Dan, Baker, Andrea, Arnautovska, Urska, Warren, Nicola, Russell, Anthony, DeMonte, Veronica, Halstead, Sean, Iyer, Ravi, Korman, Nicole, McKeon, Gemma, Medland, Sarah, Parker, Stephen, Stedman, Terry and Trott, Mike (2025). Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia. The Lancet Psychiatry, 12 (7), 493-503. doi: 10.1016/S2215-0366(25)00129-4

Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

2025

Journal Article

International Guidelines for the Algorithmic Treatment of Schizophrenia (INTEGRATE) – Authors' reply

McCutcheon, Robert A, Pillinger, Toby and Siskind, Dan (2025). International Guidelines for the Algorithmic Treatment of Schizophrenia (INTEGRATE) – Authors' reply. The Lancet Psychiatry, 12 (7), 480-481. doi: 10.1016/s2215-0366(25)00142-7

International Guidelines for the Algorithmic Treatment of Schizophrenia (INTEGRATE) – Authors' reply

2025

Journal Article

The value of mental science: we publish what matters

Malhi, Gin S., Adlington, Katherine, Al-Diwani, Adam, Ali, Shehzad, Arya, Rina, Baldwin, David S., Batley, Prathiba, Bell, Erica, Berrios, German, Beveridge, Allan, Bhat, Mohan, Bhugra, Dinesh, Biswas, Asit, Byford, Sarah, Campbell, Colin, Cass, Hilary, Chadda, Rakesh K., Chamberlain, Samuel R., Chevance, Astrid, Comasco, Erika, Cookson, John, Costello, Harry, Critchley, Hugo D., Cuijpers, Pim, de Cates, Angharad N., De Giorgi, Riccardo, de Oliveira, Claire, Drummond, Colin, Feng, Jianfeng ... Fernandez-Egea, Emilio (2025). The value of mental science: we publish what matters. The British Journal of Psychiatry, 1-5. doi: 10.1192/bjp.2025.118

The value of mental science: we publish what matters

2025

Journal Article

Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts

Tiihonen, Jari, Tanskanen, Antti, Mittendorfer-Rutz, Ellenor, Howes, Oliver D., Correll, Christoph U., Siskind, Dan and Taipale, Heidi (2025). Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts. World Psychiatry, 24 (2), 250-259. doi: 10.1002/wps.21316

Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts

2025

Journal Article

A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART

Arnautovska, Urska, Ritchie, Gabrielle, Soole, Rebecca, Menon, Anish, Korman, Nicole, Milton, Alyssa, Varnfield, Marlien, Kelly, Jaimon, Jansen, Pieter, Baker, Andrea, Ireland, Derek, Russell, Anthony, Chapman, Justin, Mulligan, Kathleen, Hirani, Shashivadan, Vitangcol, Kathryn, McKeon, Gemma and Siskind, Dan (2025). A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART. Neuropsychiatric Disease and Treatment, Volume 21, 1289-1305. doi: 10.2147/ndt.s513272

A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART

2025

Journal Article

New hope for individuals with schizophrenia: A transdisciplinary research platform to discover and translate novel treatments

McLure, James, Arnautovska, Urska, Panizzutti, Bruna, Jiang, Jiayue-Clara, Robinson, Suzanne, Drummond, Katherine D, Mohebbi, Mohammadreza, Williams, Lana J, Rossell, Susan L, Kim, Jee Hyun, Pantelis, Christos, Yung, Alison R, Siskind, Dan, Walder, Ken and Berk, Michael (2025). New hope for individuals with schizophrenia: A transdisciplinary research platform to discover and translate novel treatments. Australian & New Zealand Journal of Psychiatry, 59 (7) 00048674251342959, 48674251342959-572. doi: 10.1177/00048674251342959

New hope for individuals with schizophrenia: A transdisciplinary research platform to discover and translate novel treatments

2025

Journal Article

Increases in delivery of a brief smoking cessation intervention following implementation of a system change intervention in community psychiatry settings

Plever, Sally, Kisely, Steve, Bonevski, Billie, McCarthy, Irene, Anzolin, Melissa, Siskind, Dan, Ballard, Emma, Emmerson, Brett, Allan, John and Gartner, Coral (2025). Increases in delivery of a brief smoking cessation intervention following implementation of a system change intervention in community psychiatry settings. Australian & New Zealand Journal of Psychiatry, 59 (7) 00048674251340214, 48674251340214-611. doi: 10.1177/00048674251340214

Increases in delivery of a brief smoking cessation intervention following implementation of a system change intervention in community psychiatry settings

2025

Journal Article

Outcomes of a pilot feasibility study of comprehensive geriatric assessment for younger frail patients with severe mental illness

Arnautovska, Urska, Soole, Rebecca, Wing Ling Kwan, Winona, Reid, Natasha, Baker, Andrea, Gordon, Emily H., Hubbard, Ruth E., Siskind, Dan and Warren, Nicola (2025). Outcomes of a pilot feasibility study of comprehensive geriatric assessment for younger frail patients with severe mental illness. BMC Psychiatry, 25 (1) 473. doi: 10.1186/s12888-025-06830-3

Outcomes of a pilot feasibility study of comprehensive geriatric assessment for younger frail patients with severe mental illness

2025

Journal Article

Relationship between blood-cerebrospinal fluid barrier integrity, cardiometabolic, and inflammatory factors in schizophrenia-spectrum disorders

Yakimov, Vladislav, Jäger, Iris, Roell, Lukas, Boudriot, Emanuel, Meisinger, Verena, Campana, Mattia, Krčmář, Lenka, Halstead, Sean, Warren, Nicola, Siskind, Dan, Maurus, Isabel, Hasan, Alkomiet, Falkai, Peter, Schmitt, Andrea, Raabe, Florian J., Keeser, Daniel, Wagner, Elias and Moussiopoulou, Joanna (2025). Relationship between blood-cerebrospinal fluid barrier integrity, cardiometabolic, and inflammatory factors in schizophrenia-spectrum disorders. Brain, Behavior, & Immunity - Health, 47 101024, 101024-47. doi: 10.1016/j.bbih.2025.101024

Relationship between blood-cerebrospinal fluid barrier integrity, cardiometabolic, and inflammatory factors in schizophrenia-spectrum disorders

2025

Journal Article

Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain

Kisely, Steve, Siskind, Dan and Speyer, Helene (2025). Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain. BJPsych Open, 11 (3) e85, e85. doi: 10.1192/bjo.2025.34

Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain

2025

Journal Article

Suicide methods and severe mental illness: a systematic review and meta‐analysis

Trott, M., Suetani, S., Arnautovska, U., Kisely, S., Kar Ray, M., Theodoros, T., Le, V., Leske, S., Lu, M., Soole, R., Warren, N. and Siskind, D. (2025). Suicide methods and severe mental illness: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica, 151 (4), 467-484. doi: 10.1111/acps.13759

Suicide methods and severe mental illness: a systematic review and meta‐analysis

2025

Journal Article

Clozapine-Related Tachycardia: An Analysis of Incidence

Every-Palmer, Susanna, Northwood, Korinne, Tsakas, James, Burrage, Matthew K. and Siskind, Dan (2025). Clozapine-Related Tachycardia: An Analysis of Incidence. CNS Drugs, 39 (6) e007960, 1-11. doi: 10.1007/s40263-025-01177-5

Clozapine-Related Tachycardia: An Analysis of Incidence

2025

Journal Article

Do internalising or externalising behaviours in adolescence mediate the child maltreatment-alcohol substance use relationship?

Trott, Mike, Bull, Claudia, Najman, Jake Moses, Siskind, Dan, Arnautovska, Urska and Kisely, Steve (2025). Do internalising or externalising behaviours in adolescence mediate the child maltreatment-alcohol substance use relationship?. Addiction, 120 (7), 1413-1421. doi: 10.1111/add.70016

Do internalising or externalising behaviours in adolescence mediate the child maltreatment-alcohol substance use relationship?

2025

Journal Article

Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene Study

Lind, Penelope A., Parker, Richard K., Northwood, Korinne, Siskind, Dan J. and Medland, Sarah E. (2025). Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene Study. Schizophrenia Bulletin, 51 (2) sbae065, 458-469. doi: 10.1093/schbul/sbae065

Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene Study

2025

Journal Article

INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia

McCutcheon, Robert A, Pillinger, Toby, Varvari, Ioana, Halstead, Sean, Ayinde, Olatunde O, Crossley, Nicolás A, Correll, Christoph U, Hahn, Margaret, Howes, Oliver D, Kane, John M, Kabir, Thomas, Konradsson-Geuken, Åsa, Lennox, Belinda, Hui, Christy Lai Ming, Rossell, Susan L, Solmi, Marco, Sommer, Iris E, Taipale, Heidi, Uchida, Hiroyuki, Venkatasubramanian, Ganesan, Warren, Nicola, Agid, Ofer, Arango, Celso, de Bartolomeis, Andrea, Bittner, Robert A, Bressan, Rodrigo A, Buchanan, Robert W, Cecere, Giacomo, Chen, Eric Y H ... Siskind, Dan (2025). INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia. The Lancet Psychiatry, 12 (5), 384-394. doi: 10.1016/s2215-0366(25)00031-8

INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia

2025

Journal Article

Clozapine and treatment-resistant schizophrenia: efficacy versus effectiveness

Siskind, Dan, Northwood, Korinne and McCutcheon, Robert A (2025). Clozapine and treatment-resistant schizophrenia: efficacy versus effectiveness. The Lancet Psychiatry, 12 (4), 240-241. doi: 10.1016/s2215-0366(25)00032-x

Clozapine and treatment-resistant schizophrenia: efficacy versus effectiveness

2025

Journal Article

Genomics yields biological and phenotypic insights into bipolar disorder

O’Connell, Kevin S., Koromina, Maria, van der Veen, Tracey, Boltz, Toni, David, Friederike S., Yang, Jessica Mei Kay, Lin, Keng-Han, Wang, Xin, Coleman, Jonathan R. I., Mitchell, Brittany L., McGrouther, Caroline C., Rangan, Aaditya V., Lind, Penelope A., Koch, Elise, Harder, Arvid, Parker, Nadine, Bendl, Jaroslav, Adorjan, Kristina, Agerbo, Esben, Albani, Diego, Alemany, Silvia, Alliey-Rodriguez, Ney, Als, Thomas D., Andlauer, Till F. M., Antoniou, Anastasia, Ask, Helga, Bass, Nicholas, Bauer, Michael, Beins, Eva C. ... Andreassen, Ole A. (2025). Genomics yields biological and phenotypic insights into bipolar disorder. Nature, 639 (8056) 2417, 968-975. doi: 10.1038/s41586-024-08468-9

Genomics yields biological and phenotypic insights into bipolar disorder

2025

Book Chapter

Lifestyle in Mental and Physical Disorders

Suetani, Shuichi, Marx, Wolfgang and Siskind, Dan (2025). Lifestyle in Mental and Physical Disorders. Comorbidity between Mental and Physical Disorders. (pp. 313-331) Cham: Springer Nature Switzerland. doi: 10.1007/978-3-031-81802-8_14

Lifestyle in Mental and Physical Disorders

2025

Journal Article

A novel discovery platform for targeted drug repurposing: application for psychiatric disorders

Berk, Michael, Kim, Jee Hyun, Williams, Lana J, Liu, Zoe S J, Siskind, Dan, Panizzutti, Bruna, Yung, Alison R and Walder, Ken (2025). A novel discovery platform for targeted drug repurposing: application for psychiatric disorders. The Lancet Psychiatry, 12 (7), 535-542. doi: 10.1016/S2215-0366(25)00066-5

A novel discovery platform for targeted drug repurposing: application for psychiatric disorders

Funding

Current funding

  • 2025 - 2028
    Randomised controlled trial of screening patients with Schizophrenia for obstructive sleep apnoea using in-laboratory polysomnography or 3-nights of home oximetry (MRFF OSDMOSA led by Macquarie Uni)
    Macquarie University
    Open grant
  • 2025 - 2030
    SYNDICAT: Synergy for the Development of Innovative Clinical Treatments in Schizophrenia (Externally lead by Deakin University)
    Open grant
  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Supervision

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au